Cellular Dynamics International and Roche expand existing cardiotoxicity screening agreement
MADISON, Wis. - Cellular Dynamics International (CDI) and Roche announced today a significant expansion of their existing agreement to test drug development candidates for their potential to cause car...
read more
Sanofi wins FDA approval for Multaq heart drug
PARIS, France - Sanofi-Aventis (SASY.PA) won approval to sell heart treatment Multaq in the United States, a move that should help the French drugmaker partly recoup a future sales drop as generics to...
read more
Green stem cells in a moss: Israeli-German research consortium discovers ancient control mechanism of plant growth
FREIBURG, Germany - Although every cell of a living organism contains essentially the same genes, most animals and plants are composed of a huge variety of different cell types with special functions:...
read more
International mobilization to fight against childhood cancer in low- and middle- income countries
GENEVA, Switzerland and PARIS, France - On the initiative of the International Union Against Cancer (UICC) and sanofi-aventis, representatives from 21 countries have met in Dakar, Senegal, on July 1 a...
read more
Genzyme: The next big biotech machine
Rarely do I even acknowledge biotech equities due to the inherent risk and uncertainty in the industry. But as of late, one biotech firm has garnered my attention, due to extremely high margin of saf...
read more
Laboratoires Pierre Fabre receives positive CHMP opinion for JAVLOR in metastatic treatment of bladder cancer after failure of a prior platinum-containing regimen
CASTRES, France - Laboratoires Pierre Fabre announce today that the Committee for Medicinal Products for Human Use (CHMP), the scientific advisory committee of the European Medicines Agency (EMEA), ha...
read more
GE Healthcare to grow its health information exchange services by joining global eHealth leader
BARRINGTON, Ill. - GE Healthcare, a division of General Electric Company (NYSE:GE), and global eHealth specialist InterComponentWare, Inc. (ICW), today announced that the companies have signed a strat...
read more
Clariant launches approximately CHF 225 million Senior Unsecured Convertible Bonds due 2014
MUTTENZ, Switzerland - Clariant (SIX Swiss Exchange; CH0012142631) announces today that it intends to launch an offering (the “Offering”) of approximately CHF 225 million of senior unsecured convertib...
read more
Teva announces approval and launch of Tri-Lo Sprintec tablets
JERUSALEM, Israel - Teva Pharmaceutical Industries Ltd. (Nasdaq: TEVA) announced today that the U.S. Food and Drug Administration has granted approval for the Company's Abbreviated New Drug Applicatio...
read more
Alcon announces second quarter 2009 financial release and conference call dates
HUENENBERG, Switzerland - Alcon, Inc. (NYSE: ACL) will report on its second quarter financial results for the period ended June 30, 2009 after the market close on Wednesday, July 22, 2009.
read more
|
